Nuclear Medicine has greatly contributed to the diagnosis and treament of neuroendocrine neoplasms. This issue of PET Clinics will focus not only on the diagnosis and treatment of neuroendocrine tumors, but also theranostics. Topics include SPECT and other PET tracers, F-DOPA, Ga-DOTA-peptides, Yttrium- and Lutetium-based therapy, and the role of FDG PET. It also covers key information of theranostics.
In this issue, guest editors bring their considerable expertise to this important topic.Provides in-depth reviews on the latest updates in the field, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize
This issue of PET Clinics focuses on Molecular Imaging and Precision Medicine, Part II, and is edited by Dr. Rathan Subramaniam. Articles will include: Precision Medicine in Esophageal Cancer; Precision Medicine and PET/CT in Melanoma; Precision Medicine and PET/CT in Hepatobilliary and Pancreatic Cancer; Precision Medicine and PET/CT in Gastric Cancer; Precision Medicine and PET/CT in Skeletal and Soft Tissue Sarcomas; Precision Medicine and PET/MRI; Precision Medicine and PET/CT in Uterine and Ovarian Cancers; Precision Medicine and PET/CT in Cardiovascular Disorders, and more!
This issue of PET Clinics focuses on Theranostics and is edited by Drs. Ali Gholamrezanezhad and Hojjat Ahmadzadehfar. Articles will include: Good Clinical Practice for Theranostics; Theranostics in Neuroendocrine Tumors; Neuroendocrine Tumors: Imaging Perspective; Prostate Cancer Theranostics: From Target Description to Imaging; Prostate Cancer Theranostics: PSMA-targeted Therapy; Theranostics in Brain Tumors; Theranostics in Neuroblastoma; Theranostics in Thyroid Cancer; and more!
In this issue of Radiologic Clinics, Guest Editors Jonathan E. McConathy and Samuel J. Galgano bring their considerable expertise to the topic of PET Imaging. Top experts in the field cover key topics such as PET Imaging for lung cancer, breast cancer, melanoma, and more. - Provides in-depth, clinical reviews on PET Imaging, providing actionable insights for clinical practice. - Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field; Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews. - Contains 13 relevant, practice-oriented topics including PET Imaging for hematologic malignancies, neuroendocrine tumors, prostate and genitourinary cancers, and more.
This issue of PET Clinics examines PET/CT Imaging in Tracers Beyond FDG. Article include standardization and quantification in PET/CT imaging: tracers beyond FDG; 18F NaF PET/CT imaging; 18F NaF PET/CT imaging in pediatrics; choline PET/CT imaging for the head and neck, thorax, abdomen, and pelvis; DOPA PET/CT imaging for the head and neck, thorax, abdomen, and pelvis; 68 GaSSRTs PET/CT imaging for the head and neck, thorax, abdomen, and pelvis; FLT PET/CT imaging for the head and neck, thorax, abdomen, and pelvis; hypoxia tracers; PET/MRI tracers beyond FDG: current status and future aspects; PET/CT normal variations: effect of novel quantitative approaches; and more!
This pocket book provides up-to-date descriptions of the most relevant features of neuroendocrine tumors (NETs) and the imaging modalities currently available to assist specialists (clinicians, pathologists, radiologists, nuclear medicine physicians) in selecting optimal patient management based on interdisciplinary collaboration. As the title indicates, the focus is particularly on PET/CT, with coverage of basic principles, the available radiopharmaceuticals, indications, typical and atypical appearances, normal variants and artifacts, advantages, limitations, and pitfalls. In addition, succinct information is provided on the use of other imaging modalities, including SPECT, CT, and MRI, and on pathology and treatment options. Imaging teaching cases are presented, and key points are highlighted throughout. The book is published as part of a series on hybrid imaging that is specifically aimed at referring clinicians, nuclear medicine/radiology physicians, radiographers/technologists, and nurses who routinely work in nuclear medicine and participate in multidisciplinary meetings.
This issue of PET Clinics focuses on PET-Based Molecular Imaging in Evolving Personalized Management Design, and is edited by Drs. Abass Alavi and Sandip Basu. Articles will include: PET-Based Personalized Medicine: An Unavoidable Path for the Foreseeable Future; Personalized Management Approaches in Lymphoma: Help from PET; PET-CT in Head-Neck Malignancies: the Implications for Personalized Clinical Practice; PET Imaging of Skeletal Metastases and its Role in Personalising Further Management; PET-Based Molecular Imaging in Designing a Personalized Management Model in Neuroendocrine Tumors; Personalized Clinical Decision Making in GI Malignancies: Where Can PET Help?; PET in Breast Carcinoma: Can it Aid in Developing a Personalized Treatment Design; PET and Thyroid Cancer: Can it Help in Evolving a Personalized Treatment Design?; PET Imaging Towards Individualized Management of Urological and Gynaecological Malignancies; The Possible Role of PET Imaging towards Individualized Management of Bone and Soft Tissue Malignancies; PET-Based Personalized Management of Inflammatory Disorders; PET-Based Radiation Oncology; PET-Based Interventional Radiology; The Current and Evolving Role of PET in Personalized Management of Lung Carcinoma, and more!
This issue of PET Clinics focuses on Lung Cancer, and is edited by Drs. Gang Cheng and Timothy Akhurst. Articles will include: FDG PET/CT for lung cancer staging; Lung neoplasms with low FDG avidity; FDG PET/CT evaluation of lung cancer in populations with high prevalence of granulomatous disease; Prognostic value of FDG PET/CT; Genomic characterization of lung cancer and its impact on the use and timing of PET in therapeutic response assessment; Treatment planning for radiation therapy; Future directions of PET imaging for lung cancer; PET for RT-planning in lung cancer; Genomic characterization of lung cancer and its impact on the use and timing of PET in therapeutic response assessment; and more!
This issue of PET Clinics focuses on PET-Based Novel Imaging Techniques with Recently Introduced Radiotracers and is edited by Drs. Mona-Elisabeth R. Revheim and Abass Alavi. Articles will include: Prostate-Specific Membrane Antigen PET in Prostate Cancer: 68Ga/18F labelled; Critical Role of FDG in Hormonally Active Malignancies; Role of Amino-Acid Tracers and FDG in the Diagnosis of Brain Tumors; FACBC/Fluciclovine PET Imaging in Prostate Cancer; Somatostatin PET in NEN: DOTA-peptides + 68Ga/64Cu labelled; Imaging of Insulinoma with PET: DOTA-peptides, Exendin-4 PET/CT; Preclinical Evaluation of TSPO and MAO-B PET Radiotracers in an LPS Model of Neuroinflammation; Molecular Imaging of Movement Disorders; Imaging of Cardiac Amyloidosis; and more!
